Wealth Awesome
TSX open
Loading markets…
PARTNER SPOTLIGHT
CIBC Investor's Edge

Trade ETFs with $0 commission

Buy and sell over 200 ETFs to build your portfolio, commission-free.¹

  • ✓Over 200 eligible ETFs, commission-free when you trade online
  • ✓Screeners and tools to find ETFs that fit your goals
  • ✓Any account type, backed by the CIBC Digital Banking Guarantee

¹Online trades in ETFs on the Eligible ETF List; hold at least one business day. ETF fund fees still apply. Conditions apply.

Insider · SEDI

Zohar Krivorot

Zohar Krivorot has reported about $46.7M in shares of Cannara Biotech Inc on SEDI, Canada's insider filing system. That is #197 among the insiders we track.

Holdings as of November 17, 2026 · Director

Disclosed holdings

$46.7M

Companies

1

Buys / sells (12 months)

0 / 0

Net bought (12 months)

—

How to read insider buying

An insider buy is someone putting their own money where their mouth is, and insiders have the closest view of the business. Founders and CEOs buying their own company is common. The more telling pattern is an experienced investor holding stakes across several companies and adding over time: big buyers rarely stop at one purchase, so the first filings can put you early.

The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.

Holdings by company

Latest balance reported on SEDI for each company (direct and through holding companies), valued at the latest close.

CompanyRoleSharesValueLast filing
Cannara Biotech IncLOVE.V · all insidersDirectorincl. indirect25,519,207$46.7M2026-02-11

Track record after buying

Every open-market buy since 2016, and what the stock did 3, 6 and 12 months later (adjusted closes; same-day buys of one stock count once; each return capped at +300%). Ranked #451 on the insider track record.

Buys

6

Avg after 3 months

+0.0%

Avg after 6 months

+0.0%

Avg after 12 months

−1.6%

Up after 1 year

0% of 6

DateCompanyBought3 mo6 mo12 mo
2023-02-13Cannara Biotech IncLOVE.V$20K+0.0%+0.0%−4.2%
2023-01-25Cannara Biotech IncLOVE.V$21K+0.0%+0.0%−5.3%
2019-08-15Cannara Biotech IncLOVE.V$19K+0.0%+0.0%+0.0%
2019-08-09Cannara Biotech IncLOVE.V$62K+0.0%+0.0%+0.0%
2019-08-07Cannara Biotech IncLOVE.V$47K+0.0%+0.0%+0.0%
2019-03-13Cannara Biotech IncLOVE.V$238K+0.0%+0.0%+0.0%

Recent insider filings

DateCompanyTypeSharesPriceBalance after
2026-02-11Cannara Biotech IncCommon SharesAcquisition or disposition…-333,333$2.101,260,225
2026-01-01Cannara Biotech IncRestricted Share Units (Common Shares)Exercise of rights-375,000—0
2026-01-01Cannara Biotech IncCommon SharesExercise of rights468,750—1,593,558
2025-02-10Cannara Biotech IncRestricted Share Units (Common Shares)Exercise of rights-749,808—375,000
2025-02-10Cannara Biotech IncCommon SharesExercise of rights749,808—1,124,808
2025-01-06Cannara Biotech IncRestricted Share Units (Common Shares)Exercise of rights-375,000—1,124,808
2025-01-06Cannara Biotech IncCommon SharesExercise of rights375,000—375,000
2024-11-22Cannara Biotech IncRestricted Share Units (Common Shares)Grant of rights375,000—1,499,808
2023-12-06Cannara Biotech IncRestricted Share Units (Common Shares)Grant of rights375,000—1,124,808
2023-02-13Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Buy1,500$0.90024,258,982
2023-02-13Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Buy11,100$0.87924,257,482
2023-02-13Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Buy9,600$0.88324,246,382
2023-02-13Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Stock split or consolidation-218,131,038—24,236,782
2023-02-10Cannara Biotech IncRestricted Share Units (Common Shares)Grant of rights749,808—749,808
2023-01-25Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Buy200,000$0.105242,367,820
2020-02-19Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Acquisition or disposition…8,161,626$0.091242,167,820
2019-08-15Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Buy27,000$0.155234,006,194
2019-08-15Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Buy98,000$0.150233,979,194
2019-08-09Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Buy422,000$0.147233,881,194
2019-08-07Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Buy345,000$0.137233,459,194
2019-03-13Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Buy1,282,000$0.186233,114,194
2018-12-31Cannara Biotech IncRestricted Share Units (Common Shares)Opening Balance-Initial SE…———
2018-12-31Cannara Biotech IncOptions (Common Shares)Opening Balance-Initial SE…——6,000,001
2018-12-31Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Opening Balance-Initial SE…——231,832,194
2018-12-31Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Opening Balance-Initial SE…———
2018-12-31Cannara Biotech IncCommon Shares · via Javaa Private Equity Inc.Opening Balance-Initial SE…———
2018-12-31Cannara Biotech IncCommon SharesOpening Balance-Initial SE…———

Free with a Wealth Awesome account

Keep analysing Zohar Krivorot, free

  • Every WA Score, ranking and table
  • Insider track records and SEDI filings
  • Earnings history and analyst targets for every stock

Email only, no password, no card. Already a member? Use the same button to sign in.

How we count it: for each company we take the latest share balance Zohar Krivorot reported on SEDI for common-type shares (held directly or through holding companies) and value it at the latest close. Options, warrants and share units are left out, and so are balances with no filing in the last three years (insiders stop reporting when they leave the role). This is not a net worth figure: it covers only Canadian-listed shares reported on SEDI, and balances can lag until the next filing.

Canada's biggest insider shareholders · Latest insider trades

Awesome Portfolio™

Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →